🧫
FK866 treatment in DSS-induced colitis mouse model
active
experiment
Created: 2026-04-10T14:44:04
By: experiment_extractor
Quality:
90%
✓ SciDEX
ID: experiment-exp-ecdfc305-fcd8-4767-b8cd-a
🧫 Experiment Protocol
Animal Modelproposed
Related Entities
▸Metadata
| _origin | {'url': None, 'type': 'internal', 'tracked_at': '2026-04-10T14:44:04.648064'} |
| p_value | None |
| protocol | DSS administration to induce colitis followed by FK866 treatment with assessment of mucosal NAD levels, enzyme activities, inflammatory cell infiltration, and cytokine production |
| effect_size | None |
| sample_size | None |
| source_pmid | 28877980 |
| extracted_at | 2026-04-10T07:44:04.645402 |
| _schema_version | 1 |
| experiment_type | animal_model |
| success_criteria | Reduced colitis severity, decreased inflammatory markers, and altered immune cell populations |
| expected_outcomes | FK866 would reduce inflammation by depleting NAD and inhibiting inflammatory pathways |
| statistical_methods | None |
📊 Evidence Profile
Foundational
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
34
Outgoing
29
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.